Insilico Medicine’s leadership to address key challenges in AI drug discovery at BIO Convention

  • Post author:
  • Post category:uncategorized

Leadership from clinical stage artificial intelligence (AI)-powered drug discovery company Insilico Medicine (“Insilico”) will attend the BIO International Convention in San Diego June 3-6 and present on key issues facing AI drug discovery.